Latest news Latest news Latest news

Latest news

Portfolio

Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients

16/09/2021 - 09:57

Portfolio

Gimv leads CHF55.5M ($61M) Series A financing in Anjarium Biosciences to develop novel non-viral gene therapies.

16/09/2021 - 08:00

Portfolio

Projective Group acquires specialist data consultancy DTSQUARED

05/08/2021 - 08:41

Portfolio

Topas Therapeutics extends Series B round with an additional € 18 million (±$ 22 million)

29/07/2021 - 09:00

Corporate

Outcome of the optional dividend for the financial year 2020/2021: 63% of the dividend rights on the financial year 2020/2021 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 28.7 million

28/07/2021 - 17:45

Portfolio

The Grandeco Wallfashion Group further expands its business in wall decoration through the integration of Wall!Supply and grows to a turnover of 100 million euros

27/07/2021 - 13:30

Portfolio

Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital

26/07/2021 - 07:30

Portfolio

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

15/07/2021 - 08:00

Portfolio

Gimv transfers Summa, specialist in digital cutting solutions, to Ergon

07/07/2021 - 07:30

Portfolio

Gimv enters partnership with Klotter Elektrotechnik and lays foundation for further growth

05/07/2021 - 07:30

Portfolio

Biotalys announces successful €54.6 million Initial Public Offering

01/07/2021 - 12:02

Portfolio

Cross and Gimv form European market leader for wire mesh solutions

01/07/2021 - 07:30

Contact information

Investor Relations

Do you have any questions or require more information? Please contact us.